Exploiting Biocatalysis to make Bioplastics

This short articles explains what is biocatalysis, its mportance and how it can be used for the benefit of mankind and the environment.

The objective of this brief article is to make the reader aware of the importance of biocatalysis and how it can be used for the benefit of mankind and the environment. Biocatalysis refers to the use of biological agents, be it enzymes or living organisms to catalyse chemical reactions. The enzymes utilized can be in an isolated form or expressed within the living organism when the organism is used for catalyzing such a reaction. The advantage of using enzymes and living organisms is that they are very specific and do not yield unrelated products that is observed when using chemicals to carry out such reactions. Another advantage is that enzymes and living organisms work at less harsher conditions and are ecofriendly as opposed to chemicals being used for such transformations.

The process of catalyzing the reaction using enzymes and living organisms is known as biotransformation. Such biotransformation reactions not only occur in vivo within the human body (liver being the preferred organ; where cytochrome P450s are used to convert xenobiotics to water soluble compounds that can be excreted from the body), but also can be utilized ex vivo using microbial enzymes to perform reactions that are beneficial for mankind.

A plethora of avenues exist where biocatalysis1 and biotransformation reactions can be used for human and environmental benefit. One such area which warrants the use of such a technology is the production of plastic material, be it for manufacturing bags, cans, bottles or any such container (s), as chemically made plastics pose a huge threat to the environmental biodiversity and are non-biodegradable. They accumulate in the environment and are not able to get rid of easily. The use of enzymes and living organisms to produce bioplastics, plastics that can be easily biodegradable and pose no threat to environment would go a long way in not only reducing the chemically derived plastic waste but also help in sustaining ecosystems and prevent our flora and fauna from becoming extinct. The biodegradable containers made of bioplastic material would find use in several industries such as agri industry, food packaging, beverages and pharmaceuticals.

A variety of technologies exist today to produce bioplastics2-4. Some have been validated in the laboratory while others are still in the stage of infancy. Researches globally are working on such technologies to make them cost-effective5 and scalable so that they can be taken up to produce bioplastics in an industrial setting. These bioplastics can ultimately substitute chemically made plastics.

DOI: https://doi.org/10.29198/scieu1901 

***

Source(s)

1. Pedersen JN et al. 2019. Genetic and chemical approaches for surface charge engineering of enzymes and their applicability in biocatalysis: A review. Biotechnol Bioeng. https://doi.org/10.1002/bit.26979

2. Fai Tsang Y et al. 2019. Production of bioplastic through food waste valorization. Environment International. 127. https://doi.org/10.1016/j.envint.2019.03.076

3. Costa SS et al. 2019. Microalgae as source of polyhydroxyalkanoates (PHAs) – A review. Int J Biol Macromol. 131. https://doi.org/10.1016/j.ijbiomac.2019.03.099

4. Johnston B et al. 2018. The Microbial Production of Polyhydroxyalkanoates from Waste Polystyrene Fragments Attained Using Oxidative Degradation. Polymers (Basel). 10(9). https://doi.org/10.3390/polym10090957

5. Poulopoulou N et al. 2019. Exploring Next-Generation Engineering Bioplastics: Poly(alkylene furanoate)/Poly(alkylene terephthalate) (PAF/PAT) Blends. Polymers (Basel). 11(3). https://doi.org/10.3390/polym11030556

ABOUT THE AUTHOR

Rajeev Soni PhD (Cambridge)

dr rajeev soni

Dr Rajeev Soni holds a PhD in Molecular Biology from University of Cambridge where he was Cambridge Nehru and Schlumberger scholar. He is an experienced biotech professional and has held several senior roles in academia and industry.

The views and opinions expressed in blogs are solely those of the author(s) and other contributor(s), if any.

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

‘Transferring Memory’ From One Organism to Another a Possibility?

New study shows that it might be possible to...

Pandemic Potential of Human Metapneumovirus (hMPV) Outbreaks 

There are reports of outbreaks of Human Metapneumovirus (hMPV)...

Enhancing Drug Efficiency by Correcting 3D Orientation of Molecules

Researchers have discovered a way to design efficient medicines...

Air Pollution A Major Health Risk to the Planet: India Worst Affected Globally

Comprehensive study on the seventh biggest country of the...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has...

How Brine Shrimps survive in highly saline waters  

The brine shrimps have evolved to express sodium pumps...
Rajeev Soni
Rajeev Sonihttps://web.archive.org/web/20220523060124/https://www.rajeevsoni.org/publications/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...